The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
2-amino-1-(4-(3-(3-tert-butyl-1-(quinolin-6-yl)-1H-pyrazol-5-yl)ureido)phenyl)-1H-pyrrolo[2,3-b]quinoxaline-3-carboxamide ID: ALA4784484
PubChem CID: 118402526
Max Phase: Preclinical
Molecular Formula: C34H30N10O2
Molecular Weight: 610.68
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: CC(C)(C)c1cc(NC(=O)Nc2ccc(-n3c(N)c(C(N)=O)c4nc5ccccc5nc43)cc2)n(-c2ccc3ncccc3c2)n1
Standard InChI: InChI=1S/C34H30N10O2/c1-34(2,3)26-18-27(44(42-26)22-14-15-23-19(17-22)7-6-16-37-23)41-33(46)38-20-10-12-21(13-11-20)43-30(35)28(31(36)45)29-32(43)40-25-9-5-4-8-24(25)39-29/h4-18H,35H2,1-3H3,(H2,36,45)(H2,38,41,46)
Standard InChI Key: CCNDYGMHSHSKIW-UHFFFAOYSA-N
Molfile:
RDKit 2D
46 52 0 0 0 0 0 0 0 0999 V2000
16.5653 -14.1440 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.5641 -14.9635 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.2722 -15.3725 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.2704 -13.7351 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.9790 -14.1404 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.9798 -14.9594 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.6883 -15.3665 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
18.6827 -13.7301 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
19.3918 -14.1335 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.3949 -14.9526 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.1749 -15.2028 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
20.6539 -14.5383 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.1699 -13.8775 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.4711 -14.5352 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
20.4195 -13.0994 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.2182 -12.9264 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
19.8704 -12.4942 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
20.4306 -15.9758 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.8843 -16.5851 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.1392 -17.3607 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.9399 -17.5282 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.4853 -16.9140 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.2276 -16.1407 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.1964 -18.3041 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
21.9966 -18.4700 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.2530 -19.2459 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
22.5403 -17.8599 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
23.0532 -19.4118 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.3896 -20.1533 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
24.2018 -20.0637 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
24.3677 -19.2635 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.6579 -18.8586 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.1125 -18.9273 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.7761 -19.4042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.1937 -18.1141 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.8158 -18.5106 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.9855 -20.8613 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.1672 -20.8649 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.9973 -22.2729 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.3978 -21.5630 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.1759 -22.2804 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.7668 -21.5755 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.9536 -21.5783 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.5485 -22.2853 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.9626 -22.9909 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.7744 -22.9847 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
6 7 1 0
7 10 2 0
9 8 2 0
8 5 1 0
9 10 1 0
10 11 1 0
11 12 1 0
12 13 2 0
13 9 1 0
12 14 1 0
13 15 1 0
15 16 1 0
15 17 2 0
18 19 2 0
19 20 1 0
20 21 2 0
21 22 1 0
22 23 2 0
23 18 1 0
11 18 1 0
21 24 1 0
24 25 1 0
25 26 1 0
25 27 2 0
26 28 1 0
28 29 1 0
29 30 1 0
30 31 2 0
31 32 1 0
32 28 2 0
31 33 1 0
33 34 1 0
33 35 1 0
33 36 1 0
37 38 2 0
38 42 1 0
41 39 1 0
39 40 2 0
40 37 1 0
29 37 1 0
41 42 1 0
42 43 2 0
43 44 1 0
44 45 2 0
45 46 1 0
46 41 2 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 610.68Molecular Weight (Monoisotopic): 610.2553AlogP: 5.93#Rotatable Bonds: 5Polar Surface Area: 171.66Molecular Species: NEUTRALHBA: 9HBD: 4#RO5 Violations: 2HBA (Lipinski): 12HBD (Lipinski): 6#RO5 Violations (Lipinski): 4CX Acidic pKa: 11.56CX Basic pKa: 4.68CX LogP: 6.20CX LogD: 6.20Aromatic Rings: 7Heavy Atoms: 46QED Weighted: 0.19Np Likeness Score: -1.72
References 1. Unzue, Andrea, Jessen-Trefzer, Claudia, Spiliotopoulos, Dimitrios, Gaudio, Eugenio, Tarantelli, Chiara, Dong, Jing, Zhao, Hongtao, Pachmayr, Johanna, Zahler, Stefan, Bernasconi, Elena, Sartori, Giulio, Cascione, Luciano, Bertoni, Francesco, Sledz, Pawel, Caflisch, Amedeo, Nevado, Cristina. (2020) Understanding the mechanism of action of pyrrolo[3,2-b]quinoxaline-derivatives as kinase inhibitors, 11 (6): [PMID:33479666 ] [10.1039/d0md00049c ]